Holen Sie sich die Stockscreener-App
20.61
2.59%
0.52
Handel nachbörslich:
20.62
0.01
+0.05%
Schlusskurs vom Vortag:
$20.09
Offen:
$20.18
24-Stunden-Volumen:
1.06M
Relative Volume:
1.17
Marktkapitalisierung:
$1.30B
Einnahmen:
$330.50M
Nettoeinkommen (Verlust:
$145.42M
KGV:
12.49
EPS:
1.65
Netto-Cashflow:
$157.96M
1W Leistung:
+12.93%
1M Leistung:
+9.80%
6M Leistung:
+13.12%
1J Leistung:
+11.11%
1-Tages-Spanne:
$20.06
$20.63
1-Wochen-Bereich:
$18.21
$20.63
52-Wochen-Spanne:
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
Firmenname
Innoviva Inc
Sektor
Branche
Telefon
(650) 238-9600
Adresse
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Vergleichen Sie INVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.61 | 1.24B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Eingeleitet | Goldman | Neutral |
| 2017-11-20 | Eingeleitet | Deutsche Bank | Hold |
Alle ansehen
Innoviva Inc Aktie (INVA) Neueste Nachrichten
Innoviva Specialty Therapeutics’ Antimicrobial Therapies ZEVTERA® and XACDURO® Nominated for the 2025 Prix Galien USA Best Pharmaceutical Product Award - itemonline.com
Is Innoviva Inc. being accumulated by smart moneyWealth Building Stock Watchlist - classian.co.kr
Sentiment Turns Positive on Innoviva Inc. — Reversal AheadRisk Adjusted Technical Entry Plan Gains Followers - 선데이타임즈
Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update - Financial Times
Is Innoviva Inc. a play on infrastructure spendingFree Watchlist with Entry Points - newsyoung.net
Innoviva’s Royalties Keep Cash Flowing Despite Mixed Market Returns - Finimize
Why Innoviva (INVA) Is Up 5.7% After Reporting a Return to Profitability in Q2 - simplywall.st
Results: Innoviva, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - 富途牛牛
HC Wainwright Raises Innoviva Price Target to $45.00, Boosts Buy Rating - AInvest
Innoviva's Q2 Earnings Outperform Expectations; Price Target Raised to $45 by H.C. Wainwright - AInvest
Innoviva's Specialty Therapeutics, Royalty Portfolio to Drive Outperformance, Oppenheimer Says - MarketScreener
Analysts Initiate Coverage on Arm Holdings with Bullish Predictions - AInvest
This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday - Benzinga
Can trapped investors hope for a rebound in Innoviva Inc.Real-Time Signal Tracking with Entry Level - Newser
Innoviva’s Commercial Bet Pays Off As Shares Jump - Finimize
How Innoviva Inc. stock performs during market volatilityTop Performing Stocks to Watch - thegnnews.com
Innoviva, Inc. Just Recorded A 54% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Innoviva, Inc. Just Beat EPS By 54%: Here's What Analysts Think Will Happen Next - ca.finance.yahoo.com
Zurcher Kantonalbank Zurich Cantonalbank Cuts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Inc Q2 2025 Earnings: Revenue Misses Estimates, EPS at $1.01, Royalty Revenue at $67.3 Million - AInvest
Innoviva Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Avantax Advisory Services Inc. Has $372,000 Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Reports Strong Q2 2025 Financial Results - The Globe and Mail
Innoviva: Q2 Earnings Snapshot - New Haven Register
Innoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva (INVA) Q2 Sales Jump 64% - AOL.com
Innoviva (INVA) Q2 Sales Jump 64% - The Motley Fool
Innoviva Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Innoviva Q2 revenue $67.3mln, IST sales up 54% YoY to $29mln. - AInvest
Earnings Flash (INVA) Innoviva, Inc. Reports Q2 Revenue $100.3M, vs. FactSet Est of $92.0M - MarketScreener
What risks could impact Innoviva Inc. stock performanceTrend Analysis for Safer Market Entries - Newser
Innoviva Inc. Inches Toward Key Resistance — Will It BreakStock Selection With High Accuracy Based on Models - metal.it
Earnings visualization tools for Innoviva Inc.Smart Trend Analysis With Buy Point Cues - Newser
What catalysts could drive Innoviva Inc. stock higher in 2025Invest confidently with real-time data - Jammu Links News
Is it the right time to buy Innoviva Inc. stockAchieve breakthrough investment performance - Jammu Links News
What are analysts’ price targets for Innoviva Inc. in the next 12 monthsGet expert insights on market-moving stocks - Jammu Links News
Is Innoviva Inc. stock overvalued or undervaluedBuild wealth faster with consistent investment plans - Jammu Links News
What data driven models say about Innoviva Inc.’s futureMonthly Long-Term Market Recap and Summary - Newser
Is Innoviva’s (INVA) Accelerating EBIT Growth Reshaping Its Debt Management Playbook? - simplywall.st
Visualizing Innoviva Inc. stock with heatmapsWeekly Outlook for Short Term Investors - newser.com
Published on: 2025-08-03 13:24:33 - Jammu Links News
Should I hold or sell Innoviva Inc. stock in 2025Powerful market insights - Jammu Links News
What analysts say about Innoviva Inc. stockHigh-performance investment picks - Jammu Links News
Why is Innoviva Inc. stock attracting strong analyst attentionExtraordinary performance - Jammu Links News
When is Innoviva Inc. stock expected to show significant growthBuild wealth with high-performing stocks - Jammu Links News
What is Innoviva Inc. company’s growth strategyCapitalize on market trends with confidence - Jammu Links News
What makes Innoviva Inc. stock price move sharplyExceptional portfolio growth - Jammu Links News
Is it time to cut losses on Innoviva Inc.Free Triple Digit Growth Focused Trade Plan - Newser
Does Innoviva Inc. stock perform well during market downturnsReal Time Planner For Fast Growth - jammulinksnews.com
Is Innoviva Inc. Stock Overbought or Oversold RSI Indicator Analysis5-Year Price Trend Summary and Analysis - Newser
Innoviva (NASDAQ:INVA) Seems To Use Debt Rather Sparingly - 富途牛牛
Finanzdaten der Innoviva Inc-Aktie (INVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Innoviva Inc-Aktie (INVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):